Lastone Chitembo
Biographic Data
| ID | 7734130 |
|---|---|
| NAME | Lastone Chitembo |
| GIVEN NAMES | Lastone |
| FAMILY NAME | Chitembo |
| SIGNATURE | CHITEMBO L |
| AFFILIATIONS | World Health Organization - Zambia |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Maintaining HIV testing and treatment services in Zambia during Covid-19
BACKGROUND: Coronavirus disease 2019 (COVID-19) is caused by a virus called severe acute respiratory syndrome coronavirus. As countries struggled to control the spread of the virus through among other measures closure of health facilities, repurposing of health care workers, and restrictions on people's movement, HIV service delivery was affected. OBJECTIVES: To assess the impact of COVID-19 on HIV service delivery in Zambia by comparing uptake o…
The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention
Differentiated service delivery and new products, such as long-acting injectable cabotegravir (CAB-LA) and the dapivirine vaginal ring (DVR), could increase uptake and use of pre-exposure prophylaxis (PrEP) for HIV prevention. We explored PrEP provider perspectives on differentiated PrEP service delivery and new PrEP products to inform World Health Organization (WHO) guidelines and programme implementation. 150 PrEP providers who participated in …
No prominent works on this page.
Maintaining HIV testing and treatment services in Zambia during Covid-19
BACKGROUND: Coronavirus disease 2019 (COVID-19) is caused by a virus called severe acute respiratory syndrome coronavirus. As countries struggled to control the spread of the virus through among other measures closure of health facilities, repurposing of health care workers, and restrictions on people's movement, HIV service delivery was affected. OBJECTIVES: To assess the impact of COVID-19 on HIV service delivery in Zambia by comparing uptake o…
The Future of Pre-Exposure Prophylaxis (PrEP) for HIV Prevention
Differentiated service delivery and new products, such as long-acting injectable cabotegravir (CAB-LA) and the dapivirine vaginal ring (DVR), could increase uptake and use of pre-exposure prophylaxis (PrEP) for HIV prevention. We explored PrEP provider perspectives on differentiated PrEP service delivery and new PrEP products to inform World Health Organization (WHO) guidelines and programme implementation. 150 PrEP providers who participated in …
HIV/AIDS Research and Interventions (2 works) · Medicine (2 works) · Business (1 work) · COVID-19 Clinical Research Studies (1 work) · COVID-19 Impact on Reproduction (1 work) · Demography (1 work) · Disease (1 work) · Family medicine (1 work) · HIV, Drug Use, Sexual Risk (1 work) · Human immunodeficiency virus (HIV (1 work)